Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation
World Journal of Biological Chemistry · 27.09.2022 · 13 (4) · 72-82
DOI: 10.4331/wjbc.v13.i4.72 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Biological Chemistry, online erschienen am 27.09.2022. Verfasst von Malwina Rybicka-Ramos und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Specialist Hospital No. 1 in Bytom, Bytom 41-902, Poland. malwina.rybicka@gmail.com. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND: Allogeneic hematopoietic stem cell transplantation (allo-HSCT) may be related to the occurrence of complications, including graft-versus-host disease (GvHD) and infections. The pathogenesis of acute GvHD is connected with T lymphocytes, which identify alloantigens on host's antigen-presenting cells, activate production of interferon-gamma (IFN-gamma) and interleukin-2 (IL-2), and act on the immune effector cells and damage tissues and organs. AIM: The aim of the study was to investigate and distinguish serum concentration profiles of IFN-gamma and IL-2 within a 30-d period after allo-HSCT. METHODS: We enrolled 62 patients, i.e., 30 (48%) male and 32 (52%) female subjects [median age 49.5 (19-68) years], after allo-HSCT from siblings (n = 12) or unrelated donors (n = 50) due to acute myeloid leukemia with myeloablative conditioning (n = 26; 42%) and with non-myeloablative conditioning (n = 36; 58%). All patients were given standard immunosuppressive therapy with cyclosporin-A and methotrexate and pre-transplant antithymocyte globulin in the unrelated setting. Blood samples were collected pre-transplant before and after (on day -1) the conditioning therapy and on days +2,+4, +6, +10, +20, and +30 after allo-HSCT. Serum levels of IL-2 and IFN-gamma were determined using ELISA. RESULTS: Patients were divided into four groups depending on the presence of acute GvHD and clinical manifestations of infection. Group I included patients with neither acute GvHD nor infections [n = 15 (24%)], group II consisted of patients with infections without acute GvHD [n = 17 (27%)], group III was comprised of patients with acute GvHD without infections [n = 9 (15%)], and group IV included patients with both acute GvHD and infections [n = 21 (34%)]. IFN-gamma concentrations were higher in Group II than in other groups on days +20 (P = 0.014) and +30 (P = 0.008). Post-hoc tests showed lower concentrations of IFN-gamma on day +30 in groups I (P = 0.039) and IV (P = 0.017) compared to group II. The levels of IL-2 were mostly undetectable. CONCLUSION: Serum levels of IFN-gamma following allo-HSCT progressively escalate. High serum levels of IFN-gamma are related to infectious complications rather than acute GvHD. Serum concentrations of IL-2 in most patients are undetectable.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology, Specialist Hospital No. 1 in Bytom, Bytom 41-902, Poland. malwina.rybicka@gmail.com.
- Department of Hematology, University of Rzeszow, College of Medical Sciences, Institute of Medical Sciences, Rzeszów 35-315, Poland.
- Department of Histology and Embryology, School of Medicine in Katowice, Medical University of Silesia, Katowice 40-752, Poland.
- Department of Population Health, Division of Epidemiology and Health Education, Wroclaw Medical University, Wrocław 51-618, Poland.
- Department of Bone Marrow Transplantation and Hematooncology, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice 44-102, Poland.
- Department of Hematology and Bone Marrow Transplantation, SPSK-M Hospital, Katowice 40-027, Poland.
Zitieren
APA
Rybicka-Ramos, M., Markiewicz, M., Suszka-Świtek, A., Wiaderkiewicz, R., Mizia, S., Dzierżak-Mietła, M., & Białas, K. (2022). Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation. World Journal of Biological Chemistry, 13(4), 72-82. https://doi.org/10.4331/wjbc.v13.i4.72
Vancouver
Rybicka-Ramos M, Markiewicz M, Suszka-Świtek A, Wiaderkiewicz R, Mizia S, Dzierżak-Mietła M, et al. Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation. World Journal of Biological Chemistry. 2022;13(4):72-82. doi:10.4331/wjbc.v13.i4.72
BibTeX
@article{RybickaRamos2022,
author = {Rybicka-Ramos, Malwina and Markiewicz, Mirosław and Suszka-Świtek, Aleksandra and Wiaderkiewicz, Ryszard and Mizia, Sylwia and Dzierżak-Mietła, Monika and Białas, Krzysztof},
title = {Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation},
journal = {World Journal of Biological Chemistry},
year = {2022},
volume = {13},
number = {4},
pages = {72--82},
doi = {10.4331/wjbc.v13.i4.72}
}
EUVIMED